Nonopioid Pain Control After Labral Surgery

This study is comparing two ways to manage pain after labral surgery (surgery on the shoulder or hip joint). One group will receive a non-opioid pain regimen, which includes medications like Celecoxib, Ketorolac, Gabapentin, and Acetaminophen. The other group will receive the traditional pain control, which includes Hydrocodone-Acetaminophen (a narcotic). Researchers want to see if the non-opioid approach can reduce pain as effectively. You may be able to join if you are an adult over 18 and are scheduled for labral surgery. The study will measure your pain levels and how you feel about your recovery 10 days after surgery. The study aims to enroll 100 participants.

Study design
This is a randomized, single-blinded study comparing two treatment groups. About 100 participants will be enrolled.
What's involved
You will be assigned to one of two pain management groups. Your pain levels and recovery will be tracked daily using a journal and at your first post-operative appointment, which is within one week of surgery.
Compensation
Not stated in the trial record.
Follow-up
Your pain levels and patient-reported outcomes will be measured for 10 days post-operatively.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03825809

Nonopioid Analgesia After Labral Surgery

Recruiting
PHASE2Ages 18+InterventionalTreatment
Henry Ford Health System
~100 participants
Updated 2019-01-31 on ClinicalTrials.gov
What's tested:CelecoxibHydrocodone-AcetaminophenKetorolacGabapentinAcetaminophenDiazepam

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Pain Levels
Measured over 10 days post-operatively
+1 more outcome measured
Narcotic Use

NCT03825809

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Henry Ford Health System

    Detroit, Michiganno site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Toufic R Jildeh, MD · PRINCIPAL_INVESTIGATOR · Henry Ford Health System

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All adult patients over age 18 and scheduled for a primary or revision labral surgery
  • Pain Levels10 days post-operatively

    Patients recorded pain levels 3 times per day using Visual analog scales until study completion. Average daily pain was calculated for each patient. Higher values portend worse control.

  • Patient-Reported Outcomes Measurement Information System10 days post-operatively

    Patient-Reported Outcomes Measurement Information System Physical Interference (PROMIS PI) nightly until study completion. Average PROMIS PI values calculated nightly. A higher score indicates more pain interference.